Related Experiment Video
Updated: Jul 17, 2026

Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease
Published on: May 22, 2026
Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the
Hans Persson1, Eva Lonn, Magnus Edner
1Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital Department of Cardiology, Stockholm, Sweden. hans.persson@ds.se
Insights
Diastolic dysfunction (DD) predicts cardiovascular death or heart failure hospitalization in patients with preserved ejection fraction (HF-PSF). Moderate to severe DD indicates a poor prognosis, highlighting the need for its objective assessment in HF-PSF.
Area of Science:
- Cardiology
- Heart Failure Research
- Echocardiography
Background:
- Over 40% of heart failure (HF) hospitalizations involve patients with preserved systolic function (HF-PSF).
- Diastolic dysfunction (DD) is implicated as a primary cause of HF-PSF clinical manifestations.
Purpose of the Study:
- To investigate if diastolic dysfunction (DD) is a significant predictor of cardiovascular (CV) death or heart failure (HF) hospitalization.
- To assess the prognostic value of DD in patients with ejection fraction (EF) >40% within the CHARM-Preserved study.
Main Methods:
- Doppler echocardiography was used to assess diastolic function, classifying patients into four groups: normal, mild, moderate, and severe DD.
- Plasma NT-pro-brain natriuretic peptide levels were also utilized for assessment.
- Patients were followed for a median of 18.7 months after randomization to candesartan or placebo.
Main Results:
- Diastolic dysfunction (DD) was identified in 67% of patients, with moderate and severe DD present in 44%.
- Patients with moderate and severe DD experienced significantly poorer outcomes (18% vs. 5%, p < 0.01).
- Multivariate analysis confirmed moderate (HR 3.7) and severe DD (HR 5.7) as independent predictors of adverse outcomes.
Conclusions:
- Objective evidence of DD is prevalent in two-thirds of HF-PSF patients.
- Moderate and severe DD are significant predictors of adverse cardiovascular outcomes in this population.
- The findings underscore the prognostic importance of objectively diagnosing DD in HF-PSF patients.
Objectives:
We tested the hypothesis that diastolic dysfunction (DD) was an important predictor of cardiovascular (CV) death or heart failure (HF) hospitalization in a subset of patients (ejection fraction [EF] >40%) in the CHARM-Preserved study.
Background:
More than 40% of hospitalized patients with HF have preserved systolic function (HF-PSF), suggesting that DD may be responsible for the clinical manifestations of HF.
Methods:
Patients underwent Doppler echocardiographic examination that included assessment of pulmonary venous flow or determination of plasma NT-pro-brain natriuretic peptide > or months after randomization to candesartan or placebo. The patients were classified into 1 of 4 diastolic function groups: normal, relaxation abnormality (mild dysfunction), pseudonormal (moderate dysfunction), and restrictive (severe dysfunction).
Results:
There were 312 patients in the study, mean age was 66 +/- 11 years, EF was 50 +/- 10%, and 34% were women. The median follow-up was 18.7 months. Diastolic dysfunction was found in 67% of classified patients (n = 293), and moderate and severe DD were identified in 44%. Moderate and severe DD had a poor outcome compared with normal and mild DD (18% vs. 5%, p < 0.01). Diastolic dysfunction, age, diabetes, previous HF, and atrial fibrillation were univariate predictors of outcome. In multivariate analysis, moderate (hazard ratio [HR] 3.7, 95% confidence interval [CI] 1.2 to 11.1) and severe DD (HR 5.7, 95% CI 1.4 to 24.0) remained the only independent predictors (p = 0.003).
Conclusions:
Objective evidence of DD was found in two-thirds of HF-PSF patients. Moderate and severe DD, which were found in less than one-half of the patients, were important predictors of adverse outcome. The results demonstrate the prognostic significance and need for objective evidence of DD in HF-PSF patients.
Related Concept Videos
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Pathophysiology of Heart Failure
Acute Coronary Syndrome III: Diagnostic Studies
Heart Failure IV: Classification and Diagnostic Evaluation